Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Denosumab
Related studies linked through entity extraction aliases.
Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women
- Status
- UNKNOWN
- Phase
- PHASE3
Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone
- Status
- UNKNOWN
- Phase
- PHASE3
Effect of Denosumab in Erosion Healing in RA
- Status
- COMPLETED
- Phase
- PHASE2
Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
- Status
- TERMINATED
- Phase
- PHASE2
Denosumab and Male Infertility: a RCT
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab Versus Bisphosphonates (Alendronate) in GIOP
- Status
- COMPLETED
- Phase
- PHASE4
Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions
- Status
- COMPLETED
- Phase
- PHASE2
Presurgical Trial of Denosumab in Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
- Status
- TERMINATED
- Phase
- PHASE4
RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE4
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Preventing Osteoporosis Using Denosumab
- Status
- COMPLETED
- Phase
- PHASE4
4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE4
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
- Status
- COMPLETED
- Phase
- PHASE2